AIM
SCYX icon

Acrospire Investment Management’s SCYNEXIS SCYX Stock Holding History

Acrospire Investment Management’s Portfolio SCYX Stock Details SCYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-28
Closed -$5K – 2134
2016
Q2 		$5K Buy
+28
New +$7.92K ﹤0.01% 1866

Other funds holding SCYX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Acrospire Investment Management's SCYX Position: Q3 2016 in Review

Acrospire Investment Management sold out of SCYNEXIS (SCYX) in Q3 2016, closing a stake of 28 shares — an estimated $5K sold.

Acrospire Investment Management first reported a position in SCYX in Q2 2016 and held it in 1 quarter. The position peaked at $5K in Q2 2016. 36 funds tracked by Wall St. Rank hold SCYX as of Q3 2016.

  • Acrospire Investment Management reported no remaining SCYNEXIS position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 28 SCYNEXIS shares in Q3 2016, an estimated $5K.
  • Acrospire Investment Management first reported a position in SCYNEXIS in Q2 2016 and held it in 1 quarter.
  • Acrospire Investment Management's SCYNEXIS position peaked at $5K in Q2 2016.
  • 36 funds tracked by Wall St. Rank held SCYNEXIS as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.